Allgemein

Researchers from Erlangen prove the benefit of booster vaccination in people with rheumatism and inflammatory bowel and skin diseases Many patients with autoimmune diseases such as rheumatism, ulcerative colitis or psoriasis have to take medication that influences the immune system. The immune syst...

For the first time, a CAR T-cell day for patients with Systemic Lupus Erythematosus (SLE) took place. The aim was for the first six patients worldwide and the entire team of the Uniklinik Erlangen to get to know each other and to learn where the idea of the therapy was developed, why it works so wel...

This year, the DFG-funded SFB1181 "Checkpoints for Resolution of Inflammation" is awarding two RESOLVE travel grants to the Congress of the German Society of Rheumatology from 31.08. to 03.09.2022 in Berlin. The RESOLVE travel grants will enable doctoral graduates in medicine and life sciences to...

Researchers have proven that the gut and bones are closely linked. In this context, studies have shown that dysregulation of the gut microbiota can have negative effects on bone. What exactly is the gut-bone axis and why is it so important will be discussed by international scientists at the Gut-...

We have all been waiting for it and now the time has finally come! INFLAMMANIA 2 is now also available in English. The exciting inflammation game is not only fun, but also informs you how the immune system defends itself against infections. You find out which close combat abilities T-killer cells ha...

We support refugee scientists from Ukraine to continue their scientific work in the field of inflammation research in Erlangen. Based on the German Research Foundation (DFG)-funded Walter Benjamin-Programme, which aims to integrate refugee scientists into the German science system at every stage ...

In the Erlangen Corona Study, comprising more than 2000 subjects, the risk for developing antibodies against the new coronavirus was tested in patients with arthritis, colitis and psoriasis by the Deutsche Zentrum für Immuntherapie (DZI) and Collaborative Research Center (CRC) 1181. The results of this study were just published in Nature Communications.